Professor Ming-Wei Wang, Director of the National Center for Drug Screening and the Chinese National Compound Library (CNCL), visited Acea Biosciences (Hangzhou) Co., Ltd. at noon on July 15, 2014. He received a warm reception by Drs. Lei Wu (Vice President), Robert Y. Wang (Vice President) and Wanhong Xu (Vice President) and Dr. Xiaofeng Wu of the company, among others. After a mid-term progress review on several bilateral collaboration projects, Dr. Ming-Wei Wang had a facility tour relative to satellite compound library - a part of CNCL and the production line for NovoCyte, a Chinese brand cytometery. In the early evening, Dr. Wang met with Dr. Min Zheng, a former Acea senior scientist and now Chief of Science and Technology Division, the First Hospital affiliated to Zhejiang University.